Documents
Application Sponsors
NDA 020241 | GLAXOSMITHKLINE LLC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Discontinued | 004 |
Prescription | 005 |
Discontinued | 006 |
Application Products
001 | TABLET;ORAL | 100MG | 1 | LAMICTAL | LAMOTRIGINE |
002 | TABLET;ORAL | 150MG | 1 | LAMICTAL | LAMOTRIGINE |
003 | TABLET;ORAL | 200MG | 1 | LAMICTAL | LAMOTRIGINE |
004 | TABLET;ORAL | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | 1 | LAMICTAL | LAMOTRIGINE |
005 | TABLET;ORAL | 25MG | 1 | LAMICTAL | LAMOTRIGINE |
006 | TABLET;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | 1 | LAMICTAL | LAMOTRIGINE |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1994-12-27 | PRIORITY |
EFFICACY; Efficacy | SUPPL | 2 | AP | 1998-08-24 | STANDARD |
EFFICACY; Efficacy | SUPPL | 3 | AP | 1998-12-14 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 1997-03-11 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 1998-03-16 | PRIORITY |
LABELING; Labeling | SUPPL | 6 | AP | 1998-03-16 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 1999-05-10 | PRIORITY |
EFFICACY; Efficacy | SUPPL | 8 | AP | 2003-01-17 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 1999-06-08 | PRIORITY |
LABELING; Labeling | SUPPL | 10 | AP | 2006-09-25 | STANDARD |
EFFICACY; Efficacy | SUPPL | 11 | AP | 2001-05-25 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 12 | AP | 2000-06-12 | PRIORITY |
LABELING; Labeling | SUPPL | 14 | AP | 2000-09-08 | STANDARD |
LABELING; Labeling | SUPPL | 15 | AP | 2001-02-23 | STANDARD |
EFFICACY; Efficacy | SUPPL | 16 | AP | 2004-01-14 | STANDARD |
EFFICACY; Efficacy | SUPPL | 17 | AP | 2003-06-20 | STANDARD |
LABELING; Labeling | SUPPL | 18 | AP | 2003-04-04 | STANDARD |
LABELING; Labeling | SUPPL | 21 | AP | 2006-09-25 | STANDARD |
LABELING; Labeling | SUPPL | 25 | AP | 2006-09-25 | STANDARD |
LABELING; Labeling | SUPPL | 26 | AP | 2006-09-25 | STANDARD |
EFFICACY; Efficacy | SUPPL | 27 | AP | 2006-09-22 | STANDARD |
LABELING; Labeling | SUPPL | 29 | AP | 2006-03-17 | STANDARD |
LABELING; Labeling | SUPPL | 35 | AP | 2014-12-30 | STANDARD |
LABELING; Labeling | SUPPL | 36 | AP | 2009-05-08 | STANDARD |
LABELING; Labeling | SUPPL | 37 | AP | 2009-04-23 | 901 REQUIRED |
LABELING; Labeling | SUPPL | 38 | AP | 2009-04-23 | STANDARD |
LABELING; Labeling | SUPPL | 39 | AP | 2013-12-20 | UNKNOWN |
LABELING; Labeling | SUPPL | 40 | AP | 2014-12-30 | UNKNOWN |
REMS; REMS | SUPPL | 43 | AP | 2010-10-24 | N/A |
LABELING; Labeling | SUPPL | 44 | AP | 2010-10-24 | UNKNOWN |
LABELING; Labeling | SUPPL | 45 | AP | 2015-03-24 | STANDARD |
LABELING; Labeling | SUPPL | 47 | AP | 2011-08-04 | UNKNOWN |
REMS; REMS | SUPPL | 48 | AP | 2011-05-31 | N/A |
LABELING; Labeling | SUPPL | 49 | AP | 2011-11-29 | UNKNOWN |
LABELING; Labeling | SUPPL | 50 | AP | 2012-08-01 | UNKNOWN |
LABELING; Labeling | SUPPL | 51 | AP | 2015-03-24 | STANDARD |
LABELING; Labeling | SUPPL | 52 | AP | 2014-06-10 | STANDARD |
EFFICACY; Efficacy | SUPPL | 53 | AP | 2015-05-18 | STANDARD |
LABELING; Labeling | SUPPL | 56 | AP | 2018-07-23 | STANDARD |
LABELING; Labeling | SUPPL | 57 | AP | 2018-06-27 | STANDARD |
LABELING; Labeling | SUPPL | 58 | AP | 2020-10-09 | STANDARD |
LABELING; Labeling | SUPPL | 59 | AP | 2019-08-14 | STANDARD |
LABELING; Labeling | SUPPL | 60 | AP | 2019-09-25 | STANDARD |
LABELING; Labeling | SUPPL | 61 | AP | 2020-08-19 | STANDARD |
LABELING; Labeling | SUPPL | 62 | AP | 2020-08-31 | STANDARD |
LABELING; Labeling | SUPPL | 64 | AP | 2021-03-31 | STANDARD |
Submissions Property Types
SUPPL | 5 | Null | 0 |
SUPPL | 7 | Null | 0 |
SUPPL | 9 | Null | 0 |
SUPPL | 12 | Null | 0 |
SUPPL | 35 | Null | 6 |
SUPPL | 38 | Null | 7 |
SUPPL | 39 | Null | 6 |
SUPPL | 40 | Null | 6 |
SUPPL | 43 | Null | 6 |
SUPPL | 44 | Null | 6 |
SUPPL | 45 | Null | 6 |
SUPPL | 47 | Null | 6 |
SUPPL | 48 | Null | 6 |
SUPPL | 49 | Null | 6 |
SUPPL | 50 | Null | 6 |
SUPPL | 51 | Null | 7 |
SUPPL | 52 | Null | 7 |
SUPPL | 53 | Null | 15 |
SUPPL | 56 | Null | 7 |
SUPPL | 57 | Null | 7 |
SUPPL | 58 | Null | 15 |
SUPPL | 59 | Null | 7 |
SUPPL | 60 | Null | 7 |
SUPPL | 61 | Null | 15 |
SUPPL | 62 | Null | 7 |
SUPPL | 64 | Null | 7 |
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
005 | Prescription | AB |
CDER Filings
GLAXOSMITHKLINE LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 20241
[companyName] => GLAXOSMITHKLINE LLC
[docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020241s060,020764s053,022251s024lbl.pdf#page=64"]
[products] => [{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"150MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"},{"drugName":"LAMICTAL","activeIngredients":"LAMOTRIGINE","strength":"50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
[labels] => [{"actionDate":"09\/25\/2019","submission":"SUPPL-60","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020241s060,020764s053,022251s024lbl.pdf\"}]","notes":""},{"actionDate":"08\/14\/2019","submission":"SUPPL-59","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020241s059,020764s052,022251s023lbl.pdf\"}]","notes":""},{"actionDate":"07\/23\/2018","submission":"SUPPL-56","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020241s056,020764s049,022251s020lbl.pdf\"}]","notes":""},{"actionDate":"06\/27\/2018","submission":"SUPPL-57","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020241s057lbl.pdf\"}]","notes":""},{"actionDate":"05\/18\/2015","submission":"SUPPL-53","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/020241s053,020764s046,022251s017lbl.pdf\"}]","notes":""},{"actionDate":"03\/24\/2015","submission":"SUPPL-51","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/020241s045s051lbl.pdf\"}]","notes":""},{"actionDate":"03\/24\/2015","submission":"SUPPL-45","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/020241s045s051lbl.pdf\"}]","notes":""},{"actionDate":"12\/30\/2014","submission":"SUPPL-40","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020241s035s040,020764s028s033,022251s002s009lbl.pdf\"}]","notes":""},{"actionDate":"12\/30\/2014","submission":"SUPPL-35","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020241s035s040,020764s028s033,022251s002s009lbl.pdf\"}]","notes":""},{"actionDate":"06\/10\/2014","submission":"SUPPL-52","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020241Orig1s052,020764Orig1s045,022251Orig1s016Lbl.pdf\"}]","notes":""},{"actionDate":"12\/20\/2013","submission":"SUPPL-39","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/020241s039,020764s032,022251s001lbl.pdf\"}]","notes":""},{"actionDate":"08\/01\/2012","submission":"SUPPL-50","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/020241s050,020764s043,022251s013lbl.pdf\"}]","notes":""},{"actionDate":"11\/29\/2011","submission":"SUPPL-49","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020241s049,020764s042,022251s012lbl.pdf\"}]","notes":""},{"actionDate":"08\/04\/2011","submission":"SUPPL-47","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020241s047,020764s040,022251s010lbl.pdf\"}]","notes":""},{"actionDate":"10\/24\/2010","submission":"SUPPL-44","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/020241s043s044,020764s036s037,022251s005s006lbl.pdf\"}]","notes":""},{"actionDate":"10\/24\/2010","submission":"SUPPL-43","supplementCategories":"REMS-Proposal","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/020241s043s044,020764s036s037,022251s005s006lbl.pdf\"}]","notes":""},{"actionDate":"05\/08\/2009","submission":"SUPPL-36","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022251,020764s029,020241s036lbl.pdf\"}]","notes":""},{"actionDate":"04\/23\/2009","submission":"SUPPL-38","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"04\/23\/2009","submission":"SUPPL-38","supplementCategories":"REMS-Proposal","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"04\/23\/2009","submission":"SUPPL-37","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020241s037s038,020764s030s031lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2006","submission":"SUPPL-26","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2006","submission":"SUPPL-25","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241SLRs10s21s25s26s27,020764SLRs3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2006","submission":"SUPPL-21","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2006","submission":"SUPPL-10","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241SLRs10s21s25s26s27,020764SLRs3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2006","submission":"SUPPL-10","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"09\/22\/2006","submission":"SUPPL-27","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf\"}]","notes":""},{"actionDate":"06\/20\/2003","submission":"SUPPL-17","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/20241se1-017,20764se1-011_lamictal_lbl.pdf\"}]","notes":""},{"actionDate":"01\/17\/2003","submission":"SUPPL-8","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/020241s008lbl.pdf\"}]","notes":""},{"actionDate":"05\/25\/2001","submission":"SUPPL-11","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/20764s5lbl.pdf\"}]","notes":""},{"actionDate":"12\/14\/1998","submission":"SUPPL-3","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/1998\\\/20241s03lbl.pdf\"}]","notes":""},{"actionDate":"08\/24\/1998","submission":"SUPPL-2","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/1998\\\/20241s2lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"150MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"LAMICTAL","submission":"LAMOTRIGINE","actionType":"50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2019-09-25
)
)